Arman A. Shahriar

Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial

Carolyn T. Bramante, John B. Buse, David Liebovitz et al. · The Lancet Infectious Diseases · 2023 · 223 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +5

Socioeconomic Diversity of the Matriculating US Medical Student Body by Race, Ethnicity, and Sex, 2017<b>-</b>2019

Arman A. Shahriar, Vikram Puram, Jonathan Miller et al. · JAMA Network Open · 2022 · 83 citations · Full text

Social Sciences, Medical Education, Health Equity +16

Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19

Carolyn T. Bramante, Kenneth B. Beckman, Tanvi Mehta et al. · Clinical Infectious Diseases · 2024 · 46 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Cancer survivors exercise at higher intensity in outdoor settings: The GECCOS trial

Jonathan Miller, Karim Thomas Sadak, Arman A. Shahriar et al. · Pediatric Blood & Cancer · 2020 · 15 citations

Medicine, Oncology, Cancer Rehabilitation +10

Characteristics and Price Increases Among Sole-Source, Off-Patent Drugs in the United States, 2008 to 2018

Jonathan D. Alpern, Arman A. Shahriar, Min Xi et al. · JAMA Network Open · 2020 · 13 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +17